NDC 0781-3240-48 - Ciprofloxacin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0781-3240
- Requested NDC
- 0781-3240-48
- Package NDCs from labels
- 0781-3240-48, 0781-3240-09
- Manufacturer
- Sandoz Inc
- Effective date
- 2015-03-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ciprofloxacin - Sandoz Inc | Sandoz Inc | 2015-03-10 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0781-3240-09 | 2020-05-07 | C162847 | 48780-1 | 9d75b9d0-c913-f424-e053-dadaa90a57ce | CIPROFLOXACIN INJECTION, USP For Intravenous Infusion |
| 0781-3240-09 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-c913-f424-e053-dadaa90a57ce | CIPROFLOXACIN INJECTION, USP For Intravenous Infusion |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0781-3240-09 | ML - Milliliter | 0781-3240 | 26f2bfa5-647f-4847-9bd6-f0d02c4f9eb9 | 1 | 2013-02-13 |
| 0781-3240-48 | ML - Milliliter | 0781-3240 | 52741a5a-a431-476a-8a24-28b20fbfeeda | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| CIPROFLOXACIN | ACTIVE INGREDIENT | 5E8K9I0O4U | CIPROFLOXACIN INJECTION [SANDOZ INC] | 12 | |
| CIPROFLOXACIN | ACTIVE MOIETY | 5E8K9I0O4U | CIPROFLOXACIN INJECTION [SANDOZ INC] | 12 | |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | LX22YL083G | CIPROFLOXACIN INJECTION [SANDOZ INC] | 12 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | CIPROFLOXACIN INJECTION [SANDOZ INC] | 12 | |
| LACTIC ACID | INACTIVE INGREDIENT | 33X04XA5AT | CIPROFLOXACIN INJECTION [SANDOZ INC] | 12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dextrose | DEXTROSE MONOHYDRATE | Henry Schein, Inc. | 8cf6943f-16e8-4521-863c-09bb0b55e2a9 | 2026-09-09 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose | DEXTROSE MONOHYDRATE | REMEDYREPACK INC. | b8b77421-d687-45aa-82f6-d49bce644c10 | 2026-08-31 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | Fresenius Kabi USA, LLC | df18a603-ca12-4b26-83b5-9dd07b6453ab | 2026-08-18 | Warnings, Adverse reactions | LX22YL083G |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | bbc5b820-4973-11e2-a192-0002a5d5c51b | 2026-08-18 | Warnings, Adverse reactions | LX22YL083G |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | c29bdfa0-4976-11e2-939b-0002a5d5c51b | 2026-08-18 | Warnings, Adverse reactions | LX22YL083G |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | 515dcee0-3e34-11e2-a25f-0800200c9a66 | 2026-08-18 | Warnings, Adverse reactions | LX22YL083G |
| Ciprofloxacin | CIPROFLOXACIN | Sagent Pharmaceuticals | f406e796-17d9-4465-b8a7-00d966a4ba74 | 2026-08-04 | Boxed warning, Warnings, Adverse reactions | ANDA078252 5E8K9I0O4U |
| Delflex | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care de Mexico, S.A. de C.V. | a98facd6-9daa-4d37-8209-63a0599dbfaa | 2026-07-27 | Warnings, Adverse reactions | LX22YL083G |
| PRENATE Restore | ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, FOLIC ACID, PYRIDOXINE HYDROCHLORIDE, CYANOCOBALAMIN, BIOTIN, CALCIUM CARBONATE, FERROUS FUMARATE, MAGNESIUM OXIDE, LACTIC ACID AND DOCONEXENT | Avion Pharmaceuticals, LLC | 1076ba9a-0168-492f-ba9b-99fa02186092 | 2026-07-23 | Boxed warning, Warnings, Adverse reactions | 33X04XA5AT |
| Dextrose | DEXTROSE MONOHYDRATE | Hospira, Inc. | 4ed365da-4e62-4329-c1b9-c197ab4fb6e1 | 2026-07-13 | Warnings, Adverse reactions | LX22YL083G |
| Infant Dextrose | DEXTROSE | Henry Schein, Inc. | ce71d929-d11e-444c-bd45-e025d5172057 | 2026-07-13 | Warnings, Adverse reactions | LX22YL083G |
| SKIN TAG REMOVER | SALICYLIC ACID | Guangzhou ChuanMa International Trading Co.,Ltd. | 3a5e2105-7125-183c-e063-6394a90ae879 | 2026-07-02 | Warnings | 33X04XA5AT |
| WART SKIN TAG REMOVER | SALICYLIC ACID | Guangzhou ChuanMa International Trading Co.,Ltd. | 3a5b64a3-b19e-8b1a-e063-6294a90a6641 | 2026-07-02 | Warnings | 33X04XA5AT |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fd8a72-0527-df0c-e063-6294a90abe75 | 2026-06-24 | LX22YL083G | |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fddca1-b40c-7af0-e063-6294a90a410e | 2026-06-24 | LX22YL083G | |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fdf83e-f641-1f69-e063-6394a90ab750 | 2026-06-24 | LX22YL083G | |
| Dextrose | DEXTROSE MONOHYDRATE | Hospira, Inc. | 672264e3-9709-4bba-2a9d-12bf70c7396a | 2026-06-24 | Warnings, Adverse reactions | LX22YL083G |
| ACD A | CITRIC ACID MONOHYDRATE, DEXTROSE MONOHYDRATE, AND TRISODIUM CITRATE DIHYDRATE | Terumo BCT, Ltd. | 395aec48-198a-4aed-8e38-7accfb3232f9 | 2026-06-15 | Warnings, Adverse reactions | LX22YL083G |
| BM BM182 DROPS | HEPAR SULF, GRAPHITES, MERC SOL, MURIATIC ACID | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 5423bde6-3e31-38b0-e063-6294a90afb2d | 2026-06-13 | Warnings | QTT17582CB |
| BM BM182 DROPS | HEPAR SULF, GRAPHITES, MERC SOL, MURIATIC ACID | BM Private Limited | 540d11e3-e4a1-0ca2-e063-6394a90a3c26 | 2026-06-12 | Warnings | QTT17582CB |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.